SecBot SecBot
Institutional Cluster

MIRM

Mirum Pharmaceuticals, Inc.
BULLISH
Impact 6/10
Horizonweeks Processed5mo ago
Institutional cluster: 9 buyers, 3 sellers (bullish)
Actionable Insight ▲ Bullish

The broad-based institutional accumulation, especially from passive funds and sovereign wealth, suggests the stock is being added to core portfolios ahead of the volixibat PSC Phase 3 data. However, the 45-day 13F reporting lag means these positions may already be partially unwound. Monitor upcoming Q1 2026 13F filings for confirmation of continued accumulation. The Point72 near-exit is a contrarian signal worth watching.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$99.54
T+0 close · Jun 11, 2026 · via day close
Latest settled
+1.37%
T+60 · $100.90
Vs SPY
−3.03%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 11 $99.54entry
  2. T+1 · 5mo ago −0.20%α −0.74% · $99.35
  3. T+5 · 5mo ago +2.51%α +2.08% · $102.04
  4. T+20 · 4mo ago +28.29%α +26.40% · $127.70
  5. T+60 · 2mo ago +1.37%α −3.03% · $100.90

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

A strong institutional buying cluster emerged in MIRM during Q4 2025, with 9 buyers adding $189.1M in net new positions versus 3 sellers reducing by $60.7M. The buying was dominated by mega-passive funds (State Street, BofA, Wells Fargo) and sovereign/asset managers (Norges Bank, Wellington, Deutsche Bank), suggesting broad-based conviction in Mirum's commercial-stage rare-disease portfolio. The cluster aligns with the company's strong revenue growth trajectory from Livmarli and the upcoming Phase 3 readout for volixibat in PSC.

Key Financial Metrics

Direction
accumulating
Buy Value
$391.9M
Sell Value
$60.7M
Net Flow
$128.4M

Institutional Positions

Net institutional flow: $128.4M

▲ Buyers (9)

InstitutionActionChangePosition ValueValue Δ
State StreetADD+59.2%$169.4M$70.6M
BofAADD+82.7%$56.4M$27.7M
Wells FargoDOUBLED+326.5%$9.1M$7.1M
Norges BankNEWNot reported$20.8M$20.8M
Wellington Management GroupADD+56.6%$97.8M$39.8M
Ameriprise FinancialADD+33.7%$21.4M$6.6M
Envestnet Asset ManagementDOUBLED+201.2%$1.6M$1.1M
Deutsche BankNEWNot reported$14.7M$14.7M
Mirae Asset Global InvestmentsDOUBLED+377.5%$733.0K$590.0K

▼ Sellers (3)

InstitutionActionChangePrev ValueValue Δ
InvescoTRIM-36%$7.4M-$2.3M
Point72NEAR_EXIT-75.9%$58.0M-$42.9M
Morgan StanleyTRIM-36.5%$49.1M-$15.5M

Key Facts

  • 9 institutional buyers added $189.1M in net new positions during Q4 2025, while 3 sellers reduced by $60.7M
  • State Street added $70.6M (+59.2% shares), Wellington added $39.8M (+56.6%), Norges Bank initiated a $20.8M new position
  • Point72 made a near-exit, cutting 75.9% of its position ($42.9M sold), while Morgan Stanley trimmed $15.5M (-36.5%)
  • Mega-passive funds (State Street, BofA, Wells Fargo) accounted for $105.4M of the buying, signaling index-driven accumulation
  • Sovereign wealth (Norges Bank) and active asset managers (Wellington, Deutsche Bank) added $75.3M in new/added positions

Financial Impact

9 institutional buyers accumulated $189.1M in net new positions, while 3 sellers reduced holdings by $60.7M, for a net institutional inflow of $128.4M

institutional ownershipfloat demand

Risk Factors

  • 13F data is 45+ days stale; the cluster may have been partially or fully unwound since quarter-end
  • Point72's near-exit ($42.9M sold) suggests a loss of conviction from a sophisticated quant fund
  • Mega-passive buying may reflect index rebalancing rather than fundamental conviction in Mirum's pipeline
  • Volixibat PSC Phase 3 readout is binary, a miss would reverse the accumulation thesis

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (19 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-MIRM-2025-Q4

Track record

27 reports on MIRM

Performance horizon

4 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +23.79% at T+60 after the Apr 27, 2026 report. 7 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $92.28 settles Feb 12
  2. Nov 13, 20263d ago Insider Cluster Neutral 3/10 Entry $93.54 settles Feb 12
  3. Nov 12, 20264d ago 144 Neutral 2/10 Entry $93.33 settles Feb 10
  4. Nov 10, 20266d ago 8-K Bullish 6/10 Entry $94.42 settles Feb 8
  5. Nov 4, 202612d ago 144 Neutral 2/10 Entry $93.54 settles Feb 3
  6. Nov 4, 202612d ago 144 Neutral 2/10 Entry $93.54 settles Feb 3
  7. Nov 3, 202613d ago 8-K Bullish 6/10 Entry $96.97 settles Feb 2
  8. Oct 27, 202620d ago Institutional Cluster Mixed 4/10 Entry $85.81 settles Jan 26
  9. Oct 26, 202621d ago 8-K Bullish 6/10 Entry $85.56 settles Jan 25
  10. Oct 13, 20264w ago 8-K Bullish 7/10 Entry $79.62 settles Jan 8
Showing 10 of 27

US Market Status

Market Closed · Opens in 8h 37m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 11, 2026